Saltar al contenido
Sin resultados
Zonamedica
Zonamedica
  • Uncategorized

Trump administration cuts undocumented immigrants’ access to range of federally funded programs

HHS will limit immigrants' access to more federally funded programs, like health clinics and head start.
  • admin
  • julio 12, 2025
  • Uncategorized

STAT+: Bionic knee developed by MIT researchers gives amputees a new world of motion

A bionic knee developed by Massachusetts Institute of Technology researchers is giving amputees a new world of motion.
  • admin
  • julio 12, 2025
  • Uncategorized

STAT+: Academic groups finalize counterproposal to Trump’s research overhead cuts

Ten groups representing universities, medical centers, and others have wrapped up an alternative to the Trump administration's plan to cut billions of dollars in research overhead payments.
  • admin
  • julio 11, 2025
  • Uncategorized

NIH grant cuts, FDA transparency questions, and biotech M&A

On this week's episode of "The Readout LOUD": a closer look at the NIH’s grant-cutting legal playbook, FDA transparency questions, and another big biotech acquisition.
  • admin
  • julio 11, 2025
  • Uncategorized

FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S. that will no longer be administered under an…
  • admin
  • julio 11, 2025
  • Uncategorized

STAT+: FDA won’t pay 2024 bonuses to workers who are getting laid off

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and medicine.
  • admin
  • julio 11, 2025
  • Uncategorized

STAT+: FDA publishes rejection letters sent to drugmakers, with a big caveat

The FDA published more than 200 letters that it sent to companies when it rejected their medicines, but the letters came with a caveat.
  • admin
  • julio 11, 2025
  • Uncategorized

STAT+: Brawl over Eylea gets biosimilar industry’s attention

Plus other biotech news brought to you by The Readout newsletter.
  • admin
  • julio 11, 2025
  • Uncategorized

STAT+: Pharmalittle: We’re reading about Regeneron’s patent maneuvers, FDA rejection letters, and lots more

A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to thwart competition
  • admin
  • julio 11, 2025
  • Uncategorized

STAT+: Renasant Bio, an underdog in the race to develop kidney disease therapies, raises $54.5 million

With investors and drugmakers increasingly eyeing the kidney disease space, a new company hopes to shed its underdog status to create treatments for a hard-to-treat condition.
  • admin
  • julio 11, 2025
1 2 3 4 … 8.622
Siguiente

Copyright © 2025 Zonamedica